Kepler Capital Sticks to Its Buy Rating for Valneva (0OB3)
In a report released on February 5, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research Report), with a ...
Shareholding declaration Valneva SE - January 2025
VALNEVA Declaration of shares and voting rights January 31, 2025__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue ...
Valneva stock holds $18 target on UK vaccine nod
H.C. Wainwright reaffirmed its Buy rating and $18.00 price target for Valneva (EPA:VLS) SE (NASDAQ:VALN) shares, following the recent approval of the company's Ixchiq vaccine in the United Kingdom ...
Zimmer Biomet forecasts 2025 profit below estimates
The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of ...
manilatimes19h
Nyrstar NV - Update in respect of dissolution or continuation of the Company
Nyrstar NV - Update in respect of dissolution or continuation of the Company ...